Karako 30.01190[degrees] N, 89.28306[degrees] W CSA1 Grand Banks 30.14778[degrees] N, 89.36028[degrees] W CSA2
Snake 29.63397[degrees] N, 89.56423[degrees] W CSA2
Jessie 29.63502[degrees] N, 89.61820[degrees] W CSA2
tuberculosis D18 Kll, K38 CSA2
, CSA4, TA4, TA27 CSA20 G+ bacteria -- -- -- -- G- bacteria -- -- -- -- Fungi -- -- CSA9 -- MTB, G+ and G- bacteria, and -- -- CSA15 -- fungi MTB and G+ and D6, D13, K3 CSA24 TA3, TA22 G- bacteria D16 MTB and G+ D25 -- CSA19 TA38 bacteria MTB and G- -- -- -- -- bacteria G+ and G- -- -- -- -- bacteria G+ and G- -- -- -- -- bacteria and fungi MTB and fungi -- K8 -- TA36 Total number of 5 4 7 6 active isolates No activity -- K7, K10 CSA7, CSA8, TA34 CSA11, CSA12, CSA18 Total isolates 5 6 12 7 Actinomycetes Actinomycetes from different ecosystems active only against Yercaud hills Thottabetta Munnar Siruvani hills hills M.
 Each patient's nasal patency was evaluated by measuring the cross-sectional area (CSA) of the nose at the nasal valve (CSA1), at the anterior portion of the inferior turbinate (CSA2), and at the anterior portion of the middle turbinate (CSA3).
CSA2. Likewise, active treatment increased the mean CSA2 value by 0.11 ([pm]0.424) [cm.sup.2], while placebo resulted in a mean worsening of 0.03 ([pm]0.694) [cm.sup.2].
Our results show that loratadine/pseudoephedrine treatment increased nasal cross-sectional area and nasal volume, whereas the effects of placebo were inconsistent, with a slight decrease in the mean CSA1, CSA2, and nasal volume measurements and a very slight mean increase in the CSA3 measurement.